OrbiMed’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.6M | Buy |
|
|||||
|
2025
Q1 | $77.5M | Buy |
|
|||||
|
2024
Q4 | $60.8M | Hold |
|
|||||
|
2024
Q3 | $70.2M | Hold |
|
|||||
|
2024
Q2 | $70.8M | Buy |
|
|||||
|
2024
Q1 | $51.3M | Sell |
|
|||||
|
2023
Q4 | $71.3M | Buy |
|
|||||
|
2023
Q3 | $57.5M | Hold |
|
|||||
|
2023
Q2 | $58.2M | Sell |
|
|||||
|
2023
Q1 | $56M | Sell |
|
|||||
|
2022
Q4 | $78.4M | Sell |
|
|||||
|
2022
Q3 | $108K | Sell |
|
|||||
|
2022
Q2 | $109K | Sell |
|
|||||
|
2022
Q1 | $104M | Sell |
|
|||||
|
2021
Q4 | $145M | Sell |
|
|||||
|
2021
Q3 | $159M | Sell |
|
|||||
|
2021
Q2 | $215M | Sell |
|
|||||
|
2021
Q1 | $244M | Buy |
|
|||||
|
2020
Q4 | $197M | Buy |
|
|||||
|
2020
Q3 | $181M | Hold |
|
|||||
|
2020
Q2 | $193M | Sell |
|
|||||
|
2020
Q1 | $175M | Sell |
|
|||||
|
2019
Q4 | $171M | Sell |
|
|||||
|
2019
Q3 | $143M | Sell |
|
|||||
|
2019
Q2 | $178M | Buy |
|
|||||
|
2019
Q1 | $176M | Sell |
|
|||||
|
2018
Q4 | $188M | Sell |
|
|||||
|
2018
Q3 | $308M | Sell |
|
|||||
|
2018
Q2 | $305M | Sell |
|
|||||
|
2018
Q1 | $302M | Buy |
|
|||||
|
2017
Q4 | $261M | Sell |
|
|||||
|
2017
Q3 | $315M | Buy |
|
|||||
|
2017
Q2 | $261M | Sell |
|
|||||
|
2017
Q1 | $237M | Buy |
|
|||||
|
2016
Q4 | $159M | Buy |
|
|||||
|
2016
Q3 | $141M | Sell |
|
|||||
|
2016
Q2 | $188M | Buy |
|
|||||
|
2016
Q1 | $149M | Buy |
|
|||||
|
2015
Q4 | $84.7M | Buy |
|
|||||
|
2015
Q3 | $12M | Hold |
|
|||||
|
2015
Q2 | $14.2M | Sell |
|
|||||
|
2015
Q1 | $15.9M | Sell |
|
|||||
|
2014
Q4 | $206M | Buy |
|
|||||
|
2014
Q3 | $152M | Buy |
|
|||||
|
2014
Q2 | $50M | Buy |
|
|||||
|
2014
Q1 | $11.3M | Sell |
|
|||||
|
2013
Q4 | $18.9M | Sell |
|
|||||
|
2013
Q3 | $25.6M | Buy |
|
|||||
|
2013
Q2 | $17.9M | Buy |
|